TLX 2.18% $19.57 telix pharmaceuticals limited

Forecasting Quarterly Sales Figures, page-60

  1. 1,623 Posts.
    lightbulb Created with Sketch. 689
    if

    Valuation. Newprice target of $10.35 per share equates to 20x FY23e revenue (WILSe:A$145M). Obvious caveats include major market approvals for ILLUCCIX which isthe sole current source of revenue in our model. Our unrisked PT stands at$14.00 per share. Pipeline assets (TLX250, TLX66, TLX101) account for 11% ofour risked SOTP valuation.


    back of envelope stuff

    22m for ten weeks then 26 m for twelve weeks or 104m per year
    big uplift from july 1 , say 25%

    makes annual circa $A145 pretty accurate
 
watchlist Created with Sketch. Add TLX (ASX) to my watchlist
(20min delay)
Last
$19.57
Change
-0.435(2.18%)
Mkt cap ! $6.548B
Open High Low Value Volume
$20.47 $20.76 $19.46 $27.36M 1.376M

Buyers (Bids)

No. Vol. Price($)
10 398 $19.56
 

Sellers (Offers)

Price($) Vol. No.
$19.57 849 10
View Market Depth
Last trade - 13.48pm 18/07/2024 (20 minute delay) ?
TLX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.